首页> 外文期刊>Annals of Cancer Research and Therapy >Which is better long-term survival of gastric cancer patients with Billroth I or Billroth II reconstruction after distal gastrectomy? -Impact on 20-year survival rate-
【24h】

Which is better long-term survival of gastric cancer patients with Billroth I or Billroth II reconstruction after distal gastrectomy? -Impact on 20-year survival rate-

机译:远端胃切除术后重建Billroth I或Billroth II的胃癌患者的长期生存中哪个更好? -影响20年生存率-

获取原文
           

摘要

Background : The question in the title remains unanswered and also is both old and new among gastric surgeons. Although there have been many reports about the early-stage quality of life and postoperative morbidity, they have failed to conclude about the advantages of these two reconstructions after distal gastrectomy. In this study, we summarized more than 30 years of experience and evaluated whether the Billroth I or Billroth II reconstruction procedure is better for patient survival after distal gastrectomy.Methods : From January 1977 to August 2005, a total of 1410 gastric cancer patients underwent distal gastrectomy with Billroth I (n=1184) or Billroth II (n=226) reconstruction in the Department of Gastroenterological Surgery, Tokai University. The 10- and 20-year follow-up cases numbered 980 (82.8%) and 692 (58.4%) for Billroth I, and 213 (94.2%) and 195 (86.3%) for Billroth II as of September 2009, respectively. Among them, 1015 patients (72.0%) received curative resection and were followed to evaluate the types of recurrence.Results : In the patients with Billroth I and Billroth II, the 5-, 10-, 15-, and 20-year survival rates were 77.4%, 66.6%, 56.0%, and 45.7%, and 39.7%, 32.8%, 25.9%, and 19.6%, respectively (P <0.0001; relative risk, 2.683; 95% confidence interval, 2.261?3.183). The patients in stages 1A and 4 showed significantly better survival with Billroth I than with Billroth II. The patients with Billroth II (10/86, 11.6%) showed significantly higher hematogenous recurrence than those with Billroth I (41/929, 4.4%).Conclusions : If gastric cancer patients must receive distal gastrectomy, we recommend they receive Billroth I reconstruction.
机译:背景:标题中的问题仍未得到解答,在胃外科医师中也是如此。尽管有许多关于早期生活质量和术后发病率的报道,但他们未能就远端胃切除术后这两种重建术的优势得出结论。在这项研究中,我们总结了30多年的经验,并评估了Billroth I或Billroth II重建手术对远端胃切除术后患者的生存状况是否更好。方法:从1977年1月至2005年8月,总共有1410例胃癌东海大学胃肠外科的患者接受Billroth I(n = 1184)或Billroth II(n = 226)重建进行远端胃切除术。截至2009年9月,Billroth I的10年和20年随访病例分别为980(82.8%)和692(58.4%),Billroth II的213(94.2%)和195(86.3%)。其中,有1015例患者(占72.0%)接受了根治性切除术,并进行了随访以评估其复发类型。结果:在Billroth I和Billroth II患者中,5-,10-,15-和20-年生存率分别为77.4%,66.6%,56.0%和45.7%和39.7%,32.8%,25.9%和19.6%( P <0.0001;相对风险为2.683; 95%置信区间, 2.261?3.183)。 Billroth I的1A和4期患者生存率明显高于Billroth II。 Billroth II(10/86,11.6%)患者的血源性复发明显高于Billroth I(41/929,4.4%)。结论:如果胃癌患者必须接受远端胃切除术,我们建议他们接受比尔罗斯一世重建。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号